Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.
Login5 requirements across 5 categories
Sign up to view complete requirements and analysis
7 documents available with AI summaries
This document contains the General and Special Conditions for a Goods Purchase and Sale Agreement, defining terms, interpretation rules, document hierarchy, and the subject of the contract for the acquisition of hydroxocobalamin.
This document contains special procurement conditions for the acquisition of the medicinal product hydroxocobalamin by the Ministry of Health's Centre for Extreme Health Situations.
This document is the European Single Procurement Document (ESPD) for a tender to acquire the medicinal product hydroxocobalamin by the Ministry of Health's Centre for Extreme Health Situations in Lithuania.
This document contains a tender notice for the procurement of the pharmaceutical preparation Hydroxycobalamin by the Centre for Extreme Health Situations in Lithuania.
This document contains a form for bidders to submit their proposal, including fields for supplier name and trademark, in a tender for the acquisition of the drug hydroxocobalamin.
This document contains the structure for a complete tender submission for the procurement of hydroxocobalamin, requiring a file upload.
This document contains a request for information regarding participation in a criminal organization as an exclusion criterion for a tender concerning the acquisition of hydroxocobalamin.
Sign up to view document summaries and analysis
This tender for Hydroxycobalamin is active and EU funded, featuring a clear description and available documentation. However, it lacks disclosed estimated value and specific evaluation criteria, impacting completeness and clarity.
The tender follows an open procedure and is EU funded, adhering to general regulatory compliance. However, the absence of a specified reveal date and explicit evaluation criteria introduces minor ambiguity regarding the procedural completeness. The provided CPV code is appropriate.
The description of the required product (Hydroxocobalamin) is clear. Key documents such as contract conditions and proposal forms are provided. However, the lack of specified evaluation criteria leaves room for interpretation for bidders.
Most basic information is present, including the title, reference, organization, and description. Contract duration is specified. However, the estimated value is not disclosed, and detailed eligibility or technical requirements are absent, which affects overall completeness.
The tender is conducted via e-procurement and all essential documents appear to be accessible, promoting fairness. The criteria for exclusion and eligibility are not explicitly detailed, which could be a concern, but the absence of company-specific requirements is positive.
The tender utilizes e-procurement, which is a positive aspect for practical submission. However, the specific URL for e-submission is not evident, and financing information is not detailed, slightly hindering practical application.
Key fields such as title, reference, organization, CPV, and deadlines are populated. There are no indicated disputes or suspensions. Dates appear logical, with the submission deadline preceding the opening date.
The tender is EU funded, indicating a level of adherence to EU standards. However, there is no explicit mention of green procurement, social aspects, or innovation within the provided information.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Our procurement experts prepare everything. Proven to work — you review, approve, and submit.
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required